In breast cancer cells, the disease risk allele of non-coding SNP enhances the FOXA1-binding affinity for the upstream enhancer of TOX3 gene which in turn can change TOX3 expression (Cowper-Sal·lari et al., 2012[8]) (Figure 1(Fig. 1)). This evidence concerns the gene FOXA1 and breast cancer.